)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Global medtech giants like Siemens and Philips are expanding R&D and manufacturing in India, leveraging policy support and talent to embed India in global value chains
Domestic sales of Bajaj Auto, HMSI, and Hero MotoCorp, which together have more than a 65 per cent market share, dropped in double digits
The net profit for the company was impacted due to lower operating margins and an increase in raw material cost
Exporters with manufacturing operations within the US would also be partly insulated from the new tariffs
M&M has entered into an agreement to acquire 58.96% in SML Isuzu for Rs 555 crore
The company's revenue from operations increased by 16.09 per cent Y-o-Y to ₹11,542 crore in the fourth quarter
The US already contributes a significant share, around a quarter, of Cipla's total revenues
M&M has a 52 per cent share in the sub-3.5T light commercial vehicle (LCV) market. With this transaction, M&M expects to double its market share in the >3.5T segment to 6 per cent initially
Lord's Mark, which operates across diagnostics, medtech and renewable energy, is placing strong bets on its remote patient monitoring (RPM) technology to drive global expansion
Pre-buying ahead of TREM V norms, rising construction activity to fuel demand; margins remain stable
With global trade uncertainties rising, Indian auto component manufacturers are focusing on localisation, diversification, and policy support to shield operations and tap fresh export opportunities
To commercialise transcatheter aortic valve system in India, Europe and other select markets
Indian firms have been focusing on complex generics for some time now, which insulates them partially from pricing pressures in the generics space in the US
Mergers and acquisitions (M&A) continued to gain momentum, recording nine deals worth $359 million-marking the third straight quarter of growth
The filings span multiple areas of product and process development, with a focus on electric vehicles (EVs), hydrogen-based technologies, and core vehicle systems
LCVs to account for 62% of volumes
The brand's India strategy remains focused on selective participation in segments where it can use its global resources
Richer product mix to drive Ebitda growth; margins under pressure due to rising input costs, discounting, ad-spends
As of March 2025, JSW MG Motor enjoys a 31 per cent retail market share in the EV segment, trailing only Tata Motors, which holds a 38 per cent share
The acquisition was executed through Granules' wholly owned subsidiary, Granules Peptides